231 related articles for article (PubMed ID: 16218537)
1. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
Asher I; Hammerman A; Sthoeger Z
Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
[TBL] [Abstract][Full Text] [Related]
2. New pharmacological protocols to prevent or reduce contrast media nephropathy.
Briguori C; Airoldi F; Morici N; Colombo A
Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
[TBL] [Abstract][Full Text] [Related]
3. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
Cox CD; Tsikouris JP
J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
[TBL] [Abstract][Full Text] [Related]
4. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
5. Contrast agent--associated nephrotoxicity.
Briguori C; Tavano D; Colombo A
Prog Cardiovasc Dis; 2003; 45(6):493-503. PubMed ID: 12800130
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
[TBL] [Abstract][Full Text] [Related]
7. [N-acetylcysteine protects against radiocontrast-induced nephropathy -- pro].
Weinbrenner C
Dtsch Med Wochenschr; 2005 Sep; 130(39):2226. PubMed ID: 16189761
[No Abstract] [Full Text] [Related]
8. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department.
Sinert R; Doty CI
Ann Emerg Med; 2007 Sep; 50(3):335-45, 345.e1-2. PubMed ID: 17512638
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
11. Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity.
Thompson EJ; King SL
Crit Care Nurse; 2003 Jun; 23(3):39-46. PubMed ID: 12830779
[TBL] [Abstract][Full Text] [Related]
12. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of contrast-induced nephropathy and management of high-risk patients].
Marenzi G
G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
[TBL] [Abstract][Full Text] [Related]
14. [N-acetylcysteine protects against radiocontrast-induced nephropathy -- contra].
Druml W
Dtsch Med Wochenschr; 2005 Sep; 130(39):2227. PubMed ID: 16189762
[No Abstract] [Full Text] [Related]
15. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
16. Contrast medium-induced nephropathy: strategies for prevention.
Massicotte A
Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
[TBL] [Abstract][Full Text] [Related]
17. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
18. [Contrast-induced acute renal failure].
Giannattasio M
G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A; Azadpour M; Mercado C; Hennekens CH
Am Heart J; 2006 Jan; 151(1):140-5. PubMed ID: 16368307
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
